Immunotherapy and Radiation Therapy Sequencing in Breast Cancer: A Systematic Review
It is critical that the practicing radiation oncologist understand the available evidence and safety of combined ICI with radiation therapy in breast cancer treatment.
Category
  • Breast Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Multidisciplinary Patient-Based Approach to Challenging Situations with Cervix Cancer
Cervical cancer continues to be a common cancer globally, especially in less developed regions and some underserved areas in the US where advanced stage presentations are common. Recently published clinical trials looked at addition of novel agents to standard chemoradiation.
Category
  • Gynecologic Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $0.00
Gray Zone - Put on Your Thinking Cap: A Fungating Scalp Mass
The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
Format
  • Gray Zone
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
Radiotherapy in Alzheimer's Disease: A Systematic Review
This systematic review summarizes 16 human and animal studies and registered clinical trials describing the use of radiation in the treatment of Alzheimer’s disease, including outcomes.
Category
  • Other
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
ASTRO/ESTRO Joint Session – Overview of ASTRO/ESTRO Oligometastatic NSCLC Clinical Practice Guidelines: Case-Based Interactive Discussion
One of the most exciting and rapidly evolving areas of radiation oncology is in its application to the settings of oligometastatic or metastatic disease. Some of the most significant progress has been in implementing local therapy in the management of oligometastatic NSCLC.
Category
  • Other
  • Lung Cancer
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $0.00
Science Highlights 2023: Central Nervous System Cancer
This session highlights the most clinically relevant abstracts within the Central Nervous System track of the 2023 ASTRO Annual Meeting scientific program.
Category
  • Central Nervous System
Format
  • Science Highlights
  • CME only
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Cost $0.00
Radiation-Induced Sensorineural Hearing Loss and Potential Management
This is a review of causes and treatment of sensorineural hearing loss after radiation therapy.
Category
  • Other
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Advancement in Imaging for Radiation Oncology
Various advances in imaging are changing the clinical practice for Radiation Oncology.
Category
  • Other
  • Physics
  • Genitourinary Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $0.00
2024 ASTRO Annual Refresher Course onDemand
This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidiscipl
Category
  • Breast Cancer
  • Radiobiology
  • Sarcoma/Cutaneous
  • Central Nervous System
  • Lung Cancer
  • Physics
  • Leuk/Lymph/Hema
  • Pediatric Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
Format
  • OnDemand Meeting
Credits
  • 22.75 AMA PRA Category 1 Credit™
  • 22.75 Certificate of Attendance
Cost $1,049.00
Combined Modality Therapy for Lymph Node Positive Prostate Cancer
Historically, the management of lymph node positive prostate cancer was limited to androgen deprivation therapy, but increasing data now support the use of multimodality therapy. As treatment options have expanded, patient-centered decision making has become increasingly complicated.
Category
  • Genitourinary Cancer
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $0.00

Pages